Portal de Periódicos da CAPES

Gene Therapy for Epidermolysis Bullosa

2019; Elsevier BV; Volume: 139; Issue: 6 Linguagem: Inglês

10.1016/j.jid.2018.11.036

1523-1747

M. Peter Marinkovich, Jean Y. Tang,

Autoimmune Bullous Skin Diseases

Epidermolysis bullosa is a family of diseases characterized by blistering and fragility of the skin in response to mechanical trauma. Advances in our understanding of epidermolysis bullosa pathophysiology have provided the necessary foundation for the first clinical trials of gene therapy for junctional and dystrophic epidermolysis bullosa. These therapies show that gene therapy is both safe and effective, with the potential to correct the molecular and clinical phenotype of patients with epidermolysis bullosa. Improvements in gene delivery and in preventing immune reactions will be among the challenges that lie ahead during further therapeutic development.